Treatment was promptly initiated with intravenous cefotaxime sulbactam sodium (150 mg/kg/day for 10 days) to address the underlying bacterial infection, supported by elevated C-reactive protein (CRP, 148.24 mg/L) and chest CT findings of lung consolidation. This evidence concerns the gene CRP and bacterial infectious disease.